Take a trial of UK to unlock this pageFind out more


LID 6.38p 0.0  0.0%
23/09/16 5.00k

Relative Strength (%)
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
Margin of Safety (beta)
Screens Passed
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Jan 2011 2012 2013 2014 2015 2016 2017E 2018E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
Operating Margin %
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p +7.6%

FINANCIAL BRIEF: For the fiscal year ended 31 January 2016, LiDCO Group plc revenues decreased 8% to L7.6M. Net loss totaled L416K vs. income of L343K. Revenues reflect United Kingdom segment decrease of 7% to L5.2M, Continental Europe segment decrease of 19% to L732K, Rest of World segment decrease of 20% to L536K. Net loss reflects United Kingdom segment income decrease of 16% to L2M, United States segment income decrease of 60% to L91K. more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score  
Other Ratios
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %
Recent History
Latest interim period (ended 31st Jan '16) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Jan 2017
31st Jan 2018

Price Target: 0.15
(+119.61% above Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (p) (p) (£) (p) (p)
Consensus Estimate
1m Change
3m Change
1 brokers Broker Consensus Trend
Broker Recommendations for Lidco
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts:

Named Brokers and Analysts
FinnCap Mark Brewer ,

Profile Summary

LiDCO Group Plc is a United Kingdom-based supplier of non-invasive and minimally invasive hemodynamic monitoring equipment to hospitals. The Company is engaged in the development, manufacture and sale of cardiac monitoring equipment. It operates in the segment of supply of monitors, consumables and support services associated with the use of its cardiac monitoring equipment. The Company's products include LiDCOplus, a computer-based platform monitor; LiDCOrapid, a cardiac output monitor; LiDCOview, a graphical display, and LiDCOunity, which is its hemodynamic monitor. Its LiDCOrapid is designed for multi-parameter monitoring of both depth of anesthesia and fluids. Its products are used in the treatment of high-risk patients in both critical care units and in the operating theatre. They monitor the amount of blood flowing around the body helping clinicians and nurses to ensure that organs are kept perfused with oxygenated blood by the adjustment of supportive fluid and drugs.

Directors: Matthew Sassone (CEO) , Paul Clifford (FID) 59, D. Armour (SEC) , Theresa Wallis (NEC) , Phil Cooper (NED) 52, Ian Brown (NID) ,

No. of Employees: 46 No. of Shareholders: n/a

Last Annual January 31st, 2016
Last Interim January 31st, 2016
Incorporated October 31, 1991
Public Since July 5, 2001
Shares in Issue 194,175,000
Free Float 114.7m (59.1%)
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Eligible for an ISA? a SIPP?

Address 16 Orsman Road, LONDON, N1 5QJ, United Kingdom
Web http://www.lidco.com
Phone +44 20 77491500
Contact ()
Auditors Grant Thornton UK LLP

LID Share Price Performance LIDQuote
0.0  0.0%
Traded 3:55pm · Minimum 15 min delayed · NMS: 5.00k

Latest LID News Announcements (delayed)

Upcoming LID Events
Tuesday 11th October, 2016
Half Year 2016 Lidco Group PLC Earnings Release

Recent ↓
Tuesday 12th April, 2016
Full Year 2015 Lidco Group PLC Earnings Release
Thursday 11th June, 2015 (estimate)
Lidco Group PLC Annual Shareholders Meeting
Wednesday 11th June, 2014
Lidco Group PLC Annual Shareholders Meeting

Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2016.

Should you buy LID

Access LID Analytics Now!

Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis